J.P. Morgan on Wednesday moved Beiersdorf AG O.N. (ETR:BEIG) from an "overweight" to a "neutral" rating and lowered its price target, pointing to weaker visibility on growth and a scarcity of catalysts after the company issued what the brokerage described as a "disappointing" outlook.
The downgrade follows Beiersdorf's guidance for 2026, which projects organic sales growth to be "flat to LSD%" and operating margins to sit slightly below the prior year. J.P. Morgan said that while the forecast implies a sequential pickup for the Nivea brand, "the visibility on outcome is low."
Analysts at the bank highlighted that Nivea's momentum has softened, noting growth slowed to 0.9% in 2025. That deceleration was flagged as a factor in the recent de-rating of Beiersdorf's shares.
The note described management's strategic adjustments - including measures to address weak performance in personal care subcategories such as deodorants and body wash and steps to permit more localized pricing approaches - but the analysts warned these initiatives will take time to produce measurable results. In the brokerage's view, "turning around Europe and accelerating Nivea towards LSD - MSD organic growth are likely to be the focus points to assess success," and added that this progress "may take time to crystallize."
J.P. Morgan also underscored limited near-term clarity on whether the Nivea franchise can regain traction in face care. The brokerage said there is a "limited read on the recent launch" of new face-care products and pointed to ongoing pressure on market share in Western Europe.
Given the subdued outlook and the absence of immediate catalysts to restore investor confidence, J.P. Morgan concluded it "does not see near term catalysts re-build confidence," a view that underpinned the move to a Neutral rating.
Alongside the rating change, J.P. Morgan trimmed its profit forecasts for Beiersdorf, cutting the 2026 earnings-per-share estimate by 4%. The bank expects organic sales growth to remain subdued in the near term.
While the brokerage acknowledged that the shares still exhibit value on longer-term metrics, it maintained that the combination of lackluster growth visibility, execution risks tied to the turnaround plan, and a soft start to 2026 constrains near-term upside for the stock.
What this means
- J.P. Morgan downgraded Beiersdorf to Neutral from Overweight and reduced its price target after the company issued conservative 2026 guidance.
- Management's strategic shift to fix underperforming personal care categories and adopt more localized pricing will take time to show improvement; the brokerage stressed that measurable progress may be slow to emerge.
- Near-term recovery in Nivea - particularly in face care - remains uncertain due to limited read on recent product launches and continued market share pressure in Western Europe.
Investors and market observers should therefore weigh the longer-term valuation case against near-term execution risk and subdued sales expectations when assessing the stock.